用户名: 密码: 验证码:
Hydroxyquinone O-Methylation in Mitomycin Biosynthesis
详细信息    查看全文
文摘
Mitomycins are bioreductively activated DNA-alkylating agents. One member of this family,mitomycin C, is in clinical use as part of combination therapy for certain solid tumors. The cytotoxicitydisplayed by mitomycins is dependent on their electrochemical potential which, in turn, is governed in partby the substituents of the quinone moiety. In this paper we describe studies on the biogenesis of the quinonemethoxy group present in mitomycins A and B. An engineered Streptomyces lavendulae strain in whichthe mmcR methyltransferase gene had been deleted failed to produce the three mitomycins (A, B, and C)that are typically isolated from the wild type organism. Analysis of the culture extracts from the mmcR-deletion mutant strain revealed that two new metabolites, 7-demethylmitomycin A and 7-demethylmitomycinB, had accumulated instead. Production of mitomycins A and C or mitomycin B was selectively restoredupon supplementing the culture medium of a S. lavendulae strain unable to produce the key precursor3-amino-5-hydroxybenzoate with either 7-demethylmitomycin A or 7-demethylmitomycin B, respectively.MmcR methyltransferase obtained by cloning and overexpression of the corresponding mmcR gene wasshown to catalyze the 7-O-methylation of both C9- and C9-configured 7-hydroxymitomycins in vitro.This study provides direct evidence for the catalytic role of MmcR in formation of the 7-OMe group that ischaracteristic of mitomycins A and B and demonstrates the prerequisite of 7-O-methylation for the productionof the clinical agent mitomycin C.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700